Neil Woodford
Woodford cancer treatment holding jumps 51%
Neil Woodford saw his stake in an unquoted cancer treatment company jump $35.4m (£26.6m, €30.3m) in his investment trust on Friday as it announced pricing on its initial public offering.
Investment | 20 Jun 18
Woodford boosted by soaring healthcare stock
A Neil Woodford-backed healthcare stock climbed 114% on Tuesday.
Investment | 18 Jun 18
SJP unlikely to dump the Woodford gravy train
The partnership between St James’s Place and Neil Woodford is unlikely to end any time soon, despite many discretionary fund managers and platforms dropping the star fund manager for underperformance.
Tilney boots Woodford from buy list
Tilney has ditched Neil Woodford’s flagship fund from its buy list due to performance and liquidity concerns, echoing sentiment from other platforms that have dropped the UK equities manager.
Charles Stanley Direct ditches Woodford from buy list
Charles Stanley Direct has booted Woodford Equity Income from its preferred funds list on concerns about its exposure to early stage companies.